Literature DB >> 27630537

Nanomedicine: Addressing Cardiovascular Disease and Cardiovascular Tissue Regeneration.

Rebekah A Neal1, Olugbemisola Oredein-McCoy1, Edward A Botchwey1,2.   

Abstract

Cardiovascular disease is becoming an increasingly significant problem. In attempts to overcome many of the traditional hurdles of cardiovascular disease treatment, therapeutic approaches have been gradually moving beyond an exclusive focus on orally delivered drugs towards the development of nanoscale applications. These technologies exploit molecular scale events to improve drug and gene delivery applications, enhance preventative medicine and diagnostic strategies, and create biomimicking substrates for vascular tissue engineering. As nanoscale treatments enter the arena of clinical medicine, new ways of thinking about and routes for applying nanomedicine to cardiovascular health issues are emerging. With focuses on drug delivery, gene therapy, and biomimetics, this article will provide a comprehensive review of various nanomedicine applications for combating atherosclerosis and for improving upon current vascular tissue engineering designs.

Entities:  

Year:  2009        PMID: 27630537      PMCID: PMC5019576          DOI: 10.2174/157340709789054722

Source DB:  PubMed          Journal:  Curr Bioact Compd        ISSN: 1573-4072


  44 in total

Review 1.  Local drug and gene delivery through microbubbles.

Authors:  E C Unger; E Hersh; M Vannan; T O Matsunaga; T McCreery
Journal:  Prog Cardiovasc Dis       Date:  2001 Jul-Aug       Impact factor: 8.194

Review 2.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue.

Authors:  Jayanth Panyam; Vinod Labhasetwar
Journal:  Adv Drug Deliv Rev       Date:  2003-02-24       Impact factor: 15.470

Review 3.  Coronary artery stents.

Authors:  J Al Suwaidi; P B Berger; D R Holmes
Journal:  JAMA       Date:  2000-10-11       Impact factor: 56.272

4.  Calcium phosphate nanoparticles as novel non-viral vectors for targeted gene delivery.

Authors:  Indrajit Roy; Susmita Mitra; Amarnath Maitra; Subho Mozumdar
Journal:  Int J Pharm       Date:  2003-01-02       Impact factor: 5.875

5.  Predictors of diffuse and aggressive intra-stent restenosis.

Authors:  S L Goldberg; A Loussararian; J De Gregorio; C Di Mario; R Albiero; A Colombo
Journal:  J Am Coll Cardiol       Date:  2001-03-15       Impact factor: 24.094

6.  Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis.

Authors:  Gregory M Lanza; Xin Yu; Patrick M Winter; Dana R Abendschein; Kerry K Karukstis; Michael J Scott; Lori K Chinen; Ralph W Fuhrhop; David E Scherrer; Samuel A Wickline
Journal:  Circulation       Date:  2002-11-26       Impact factor: 29.690

7.  A tough biodegradable elastomer.

Authors:  Yadong Wang; Guillermo A Ameer; Barbara J Sheppard; Robert Langer
Journal:  Nat Biotechnol       Date:  2002-06       Impact factor: 54.908

8.  Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting.

Authors:  M B Leon; P S Teirstein; J W Moses; P Tripuraneni; A J Lansky; S Jani; S C Wong; D Fish; S Ellis; D R Holmes; D Kerieakes; R E Kuntz
Journal:  N Engl J Med       Date:  2001-01-25       Impact factor: 91.245

9.  Left ventricular thrombus enhancement after intravenous injection of echogenic immunoliposomes: studies in a new experimental model.

Authors:  Andrew Hamilton; Shao-Ling Huang; Drew Warnick; Adam Stein; Mark Rabbat; Taruna Madhav; Bonnie Kane; Ashwin Nagaraj; Melvin Klegerman; Robert MacDonald; David McPherson
Journal:  Circulation       Date:  2002-06-11       Impact factor: 29.690

10.  Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery.

Authors:  Jayanth Panyam; Wen-Zhong Zhou; Swayam Prabha; Sanjeeb K Sahoo; Vinod Labhasetwar
Journal:  FASEB J       Date:  2002-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.